Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 1, 2001Blood

Improve or abandon the standardized response criteria for myelodysplastic syndromes recommended by the International Working Group

View Full Paper
Ask AI
Bookmark
Share

Authors

ARAzra RazaColumbia University Irving Medical Center

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Azra Raza (2001) studied this question.

synapsesocial.com/papers/6a9235e6ec33462ec0f0c99dhttps://doi.org/10.1182/blood.v98.1.251
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Proposal for the recognition of minimally differentiated acute myeloid leukaemia (AML‐MO)1991 · 668 citations
  2. 2Autologous bone marrow transplantation for patients with myelodysplastic syndrome (MDS) or acute myeloid leukemia following MDS. Chronic and Acute Leukemia Working Parties of the European Group for Blood and Marrow Transplantation.1997 · 105 citations
  3. 3Routine bone marrow exam during first remission of acute myeloid leukemia1996 · 18 citations
  4. 4Topotecan, a topoisomerase I inhibitor, is active in the treatment of myelodysplastic syndrome and chronic myelomonocytic leukemia1996 · 126 citations